Chronic Cough Market to Reach US$ 9,854.8 million, Globally, by 2027 at 7.8% CAGR: The Insight Partners

Chronic cough isdefined as a persistent cough that lasts long up to 6-8 weeks. It significantlyaffects the life of the patients by interrupting sleep, creating vomitingsensation, light-headedness, and even rib fractures. It is caused due tomultiple reasons such as infections, asthma, and gastro esophageal refluxdisease (GERD). The chronic cough market growth is attributed to factors suchas rising incidences of chronic cough and growing product developments to treatchronic cough are expected to drive the growth of the market. However, productrecalls is the major factor hindering the market growth.

Rising Incidences of Chronic Cough

Chronic cough is caused due to asthma, acid reflux from the stomach,and postnasal drip. The conditions such as infection, bronchitis, and lungdiseases are also likely to lead to chronic cough. The condition such as asthmais rising across the world; it is commonly seen among children and adults. Itis a major cause of the growing health burden in the US. For instance,according to the Centers for Disease Control and Prevention (CDC) datapublished in 2019, one among every three people has asthma in the US. AcrossAmerica, over 25 million people live with asthma, which accounts for ~8% inadults, and nearly 8.5% in children.

Get Sample PDF of Chronic Cough Market@ https://www.theinsightpartners.com/sample/TIPRE00011584/?utm_source=openpr-10353

In the Middle East and Africa, respiratory diseases are rising due toclimatic conditions. The countries surrounded by desserts are prone to the riskof respiratory diseases due to the easy spread of allergens. Over 60 to 70% ofpatients in the countries are diagnosed with respiratory diseases. Anothermajor cause of chronic cough among people in the region is smoking. Nearly 30%of the people are addicted to smoking, which further leads to rising incidencesof chronic cough.

Drug Class Insights

Based on drug class, the chronic cough market is segmented into antihistamines,corticosteroids, decongestants, combination drug, antibiotics, acid blockers,and other drug class. The combination drug segment held the largest share ofthe market in 2019 and the same segment is estimated to report the highest CAGRin the market during the forecast period. The growth of the segment isestimated due to benefits offered by the combination drugs such as the use ofcombination drugs can target treatment more than one symptom. Additionally, thecombination of drugs is widely available as over the counter medicines.

Route ofAdministration Insights

Based on rout of administration, the chronic cough market is segmentedinto oral, injections, inhalation, and other route of administration. The oral segmentheld the largest share of the market in 2019. However, the inhalation segmentis estimated to register the highest CAGR in the market during the forecast period.

DistributionChannel Insights

Based on distribution channel, the chronic cough market is segmentedinto hospital pharmacy, online pharmacy, and retail pharmacy. The hospitalpharmacy segment held the largest share of the market in 2019. However, the onlinepharmacy segment is estimated to register the highest CAGR in the market duringthe forecast period.

StrategicInsights

Inorganic strategies are the more commonly adopted strategies bycompanies in the chronic cough market, which enables them expand their global footprints,and product and service portfolios. The market players have also adoptedorganic strategies such as product launches strategy to enlarge their global customerbase, which also permits them to maintain their brand name globally.

Purchase Copy of This Report @ https://www.theinsightpartners.com/buy/TIPRE00011584/?utm_source=openpr-10353

Global Chronic Cough Market – By Drug Class

Antihistamines
Corticosteroids
Decongestants
Combination Drug
Antibiotics
Acid Blockers
Other Drug Class
Global Chronic CoughMarket– By Route of Administration

Oral
Injections
Nasal
OtherRoute of Administration
Global ChronicCough Market– By Distribution Channel

HospitalPharmacy
OnlinePharmacy
RetailPharmacy
Chronic Cough Market– By Geography

North America
US
Canada
Mexico
Europe
France
Germany
Italy
UK
Spain
Asia Pacific (APAC)
China
India
South Korea
Japan
Australia
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
South and Central America
Brazil
Argentina

CompanyProfiles

Novartis AG
Teva Pharmaceutical Industries Ltd
GlaxoSmithKline plc.
Bayer AG,
Mylan N.V.
Amneal Pharmaceuticals, Inc.
Cipla Inc.
Reckitt Benckiser Group plc
Sun Pharmaceutical Industries Ltd
Aurobindo Pharma Ltd

Contact:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

This release was published on openPR.